August 13, 2015Open Access
Guidelines for determination of the number of prior lines of therapy in multiple myeloma
Key Points
Key points are not available for this paper at this time.
Abstract
To the editor: The treatment of multiple myeloma is rapidly evolving. Although there are standard rules for categorizing patients based on disease stage11 and uniform response criteria for assessing clinical benefit,22 the magnitude of response seen with a given drug is also influenced by